60031-47-2 Usage
Description
1-(1-methyl-1H-pyrazol-3-yl)ethanol, also known as MPE, is a chemical compound characterized by its molecular formula C7H10N2O. It is recognized for its antioxidant and anti-inflammatory properties, which contribute to its potential as a valuable ingredient in the development of pharmaceuticals and bioactive molecules targeting oxidative stress-related conditions and inflammatory diseases.
Uses
Used in Pharmaceutical Industry:
1-(1-methyl-1H-pyrazol-3-yl)ethanol is used as a building block for the synthesis of various pharmaceuticals and bioactive molecules, due to its versatile chemical structure and beneficial properties.
Used in Cosmetics and Personal Care Industry:
1-(1-methyl-1H-pyrazol-3-yl)ethanol is used as an ingredient in the formulation of cosmetics and personal care products for its ability to protect and repair skin damage, making it a promising candidate for products aimed at skin health and rejuvenation.
Overall, MPE holds promise as a versatile and beneficial compound with a range of potential applications in medicinal and cosmetic fields, leveraging its antioxidant and anti-inflammatory properties to address various health and beauty concerns.
Check Digit Verification of cas no
The CAS Registry Mumber 60031-47-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,0,3 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 60031-47:
(7*6)+(6*0)+(5*0)+(4*3)+(3*1)+(2*4)+(1*7)=72
72 % 10 = 2
So 60031-47-2 is a valid CAS Registry Number.
60031-47-2Relevant articles and documents
-
Noyce,D.S.,Sandel,B.B.
, p. 3640 - 3642 (1976)
-
4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
-
Page/Page column 643, (2016/06/14)
The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
